Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Aurobindo Pharma Limited
AUROPHARMAAurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India. Address: Galaxy, Plot No. 1, Hyderabad, India, 500032
Analytics
WallStreetin tavoitehinta
80 176.43 INRP/E-suhde
23.214Osinkotuotto
0.32 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut AUROPHARMA
Osinkoanalytiikka AUROPHARMA
Osinkojen kasvu 5 vuoden aikana
167 %Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
10 %Osinkohistoria AUROPHARMA
Osakkeen arvostus AUROPHARMA
Talousasiat AUROPHARMA
Tuloksia | 2019 | Dynamiikka |